JASON M. NOTO, Senior VP, US Market Access, AVEO Oncology

Jason Noto serves as Senior Vice President of US Market Access at AVEO Oncology, an LG Chem Company. Since 2019, Jason has led all aspects of Market Access (Trade & Distribution, National Accounts, HUB Services, Federal Channels, and Pricing / Contracting) and spearheaded  the commercial buildout of the Function for the launch of FOTIVDA (tivozanib) for advanced Renal Cell Carcinoma in March, 2020. Prior to his time at AVEO, Jason spent 12 years in US Marketing roles with increasing responsibility at Bristol-Myers Squibb, Alkermes, and Sunovion Pharmaceuticals and has led the commercial launch of 7 specialty products over the span of his marketing tenure. Jason started his career in 2000 in sales and sales management roles spanning oncology, rare disease, and CNS therapeutic areas.

Jason graduated from LeMoyne College with a Bachelor’s Degree in Marketing and earned his Masters of Business Administration (MBA) from the Carroll School of Management at Boston College.